Back | Next |
home / stock / mynz / mynz message board
Subject | By | Source | When |
---|---|---|---|
$MYNZ Price gaining up | BlazingStocks | investorshub | 04/15/2023 11:44:24 PM |
where is the squeeze? | BlazingStocks | investorshub | 04/15/2023 10:56:36 PM |
$MYNZ is it bear time? Or do we go bull? | BlazingStocks | investorshub | 04/15/2023 9:46:38 PM |
$MYNZ What do you make of this? | Mrogers23 | investorshub | 04/15/2023 7:33:39 PM |
The gaining up | pumpnass | investorshub | 04/15/2023 3:40:49 PM |
Anyone hear anything lately? Want to see this one go | Mrogers23 | investorshub | 04/15/2023 3:05:36 PM |
$MYNZ Long and strong lets hope im right | BooDog | investorshub | 04/15/2023 2:38:59 PM |
news all the way baby | BlazingStocks | investorshub | 04/15/2023 9:41:17 AM |
$MYNZ bears are running | esi23 | investorshub | 04/15/2023 8:31:35 AM |
The gaining | Mrogers23 | investorshub | 04/15/2023 7:56:30 AM |
$MYNZ news out | BlazingStocks | investorshub | 04/15/2023 4:34:54 AM |
bears are running | pumpnass | investorshub | 04/15/2023 2:16:55 AM |
$MYNZ Price trading | BlazingStocks | investorshub | 04/15/2023 2:16:02 AM |
MomentumIts now | budfoxfun | investorshub | 04/15/2023 12:08:43 AM |
Price trading up | BlazingStocks | investorshub | 04/14/2023 8:17:44 PM |
$MYNZ The trading | BlazingStocks | investorshub | 04/14/2023 6:03:50 PM |
Price trading last trade up | pumpnass | investorshub | 04/14/2023 4:36:22 PM |
$MYNZ MomentumIts trading up | BlazingStocks | investorshub | 04/14/2023 1:20:27 PM |
$MYNZ what do you make of this data? | BlazingStocks | investorshub | 04/14/2023 12:52:02 PM |
$MYNZ Found an interesting article | budfoxfun | investorshub | 04/14/2023 11:13:07 AM |
News, Short Squeeze, Breakout and More Instantly...
BERKELEY, Calif. and MAINZ, Germany, July 25, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in early detection of cancer, today announced significant improvements to its ColoAlert product, currently being commercialized across Euro...
--News Direct-- Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer sc...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this new configuration demonstrates sens...